Viewing Study NCT01020292


Ignite Creation Date: 2025-12-24 @ 3:25 PM
Ignite Modification Date: 2025-12-26 @ 6:42 AM
Study NCT ID: NCT01020292
Status: COMPLETED
Last Update Posted: 2019-04-12
First Post: 2009-11-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module